Oral Answers to Questions

Debate between Teresa Pearce and Jonathan Djanogly

Tuesday 17th May 2011 Commons Chamber

[Teresa Pearce (Erith and Thamesmead) (Lab)]

T6. Earlier this month, the foetal anti-convulsant litigation against Sanofi Aventis was discontinued after six years’ preparation. The claimants and their families have been denied their day in court because legal aid funding was withdrawn at the last moment. Will the Minister say what funding arrangements will be available for multi-party actions in future so that such families are not denied access to justice?

[The Parliamentary Under-Secretary of State for Justice (Mr Jonathan Djanogly)]

The funding of clinical negligence cases in this country is about 50:50 between legal aid and conditional fee arrangements—in other words, private funding. We believe that when people have the opportunity of private funding, they should take that option. In looking at our proposals for reviewing privately funded litigation, we are taking clinical negligence cases on board and are moulding our proposals to help those who want to take such cases.